Skip to content

Pistachio and blood glucose response

Effect of pistachios on dietary glycemic load,cardiometabolic risk factors, and the gut microbome among Asian Indian adults with pre-diabetes-A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029340
Enrollment
120
Registered
2020-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Pistachio: Intervention arm participants will be provided approximately 60g of roasted pistachios daily as a part of everyday meal (30g/meal for 2 meals) adjusted for carbohydrate and f

Sponsors

American Pistachio Growers
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Hypertension Pre-diabetes (Impaired fasting glucose: fasting capillary blood glucose >=110mg/dl and =140mg/dl but

Exclusion criteria

Exclusion criteria: Self-reported diabetes Current daily and weekly tobacco users History of allergy to nuts Patients on oral steroids, metformin, on hormonal replacement therapy History of bariatric surgery or have underwent any major surgery in last 6 months Use of nutritional supplements Bad dentures Patients with cancer, Patients on medications for psychiatric disorders, Active weight loss (more than 3 kg in the last month) • Pregnant/lactating women Presence of severe liver, kidney, thyroid, or other endocrine diseases Any condition that hinders compliance to the intervention. Possible eating disorder

Design outcomes

Primary

MeasureTime frame
Changes in 1) fasting glucose, 2) 2hour post glucose load;Timepoint: 2 time points 1.Baseline-at the time of study commencement 2.End- at the end of 3 months

Secondary

MeasureTime frame
Changes in Insulin resistance measured by HOMA-IR Lipid profile changes in body weight and blood pressure Selected Pro-inflammatory and anti-inflammatory markers Cellular glucose uptake and mRNA gene expression studies Gut microbiome in a sub sample 24 hr glycemic response using flash glucose monitoring device.Timepoint: baseline-before commencement of study End of study-end of 3 months intervention

Countries

India

Contacts

Public ContactSudha Vasudevan

MADRAS DIABETES RESEARCH FOUNDATION

s2r_7@mdrf.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026